πŸ‡ΊπŸ‡Έ FDA
Patent

US 11970543

Anti-CD39 antibodies and use thereof

granted A61KA61K2039/505A61K31/555

Quick answer

US patent 11970543 (Anti-CD39 antibodies and use thereof) held by Arcus Biosciences, Inc. expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K31/555, A61K39/39558, A61P